converting from semaglutide to tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are converting semaglutide to tirzepatide Switching

Both studies have primary completion dates in September 2025

GLP-1 medications reduce appetite in ways that change how and how much most people eat

February 26, 2025 New NAION Study A recent study published last week in JAMA Ophthalmology investigated the potential link between semaglutide and non-arteritic anterior ischemic optic neuropathy (NAION), a rare eye condition that can lead to sudden vision loss

The reality is that its a reported side effect with several identifiable causes, most of which are correctable once you understand whats driving them

The interesting question isnt who launched almost everyone did

Notably, nausea and vomiting were predominantly mild, transie